Submitted by Anonymous (not verified) on 3 July 2026 - 7:30
Opinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: PM: decision on the application for modification of an agreed PIP, PIP number: P/0028/2023
Source: